PPARgamma in Human and Mouse Physiology

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2007 May 4

PMID 17475546

Citations 101

Authors

Sami Heikkinen

Johan Auwerx

Carmen A Argmann

Affiliations

Soon will be listed here.

Abstract

The peroxisome proliferator activated receptor gamma (PPARgamma) is a member in the nuclear receptor superfamily which mediates part of the regulatory effects of dietary fatty acids on gene expression. As PPARgamma also coordinates adipocyte differentiation, it is an important component in storing the excess nutritional energy as fat. Our genes have evolved into maximizing energy storage, and PPARgamma has a central role in the mismatch between our genes and our affluent western society which results in a broad range of metabolic disturbances, collectively known as the metabolic syndrome. A flurry of human and mouse studies has shed new light on the mechanisms how the commonly used insulin sensitizer drugs and PPARgamma activators, thiazolidinediones, act, and which of their physiological effects are dependent of PPARgamma. It is now evident that the full activation of PPARgamma is less advantageous than targeted modulation of its activity. Furthermore, new roles for PPARgamma signaling have been discovered in inflammation, bone morphogenesis, endothelial function, cancer, longevity, and atherosclerosis, to mention a few. Here we draw together and discuss these recent advances in the research into PPARgamma biology.

Citing Articles

Curcumin Modulates the Differential Effects of Fructose and High-fat Diet on Renal Damage, Inflammation, Fibrosis, and Lipid Metabolism.

Melendez-Salcido C, Ramirez-Emiliano J, Garcia-Ramirez J, Gomez-Garcia A, Perez-Vazquez V Curr Pharm Des. 2024; 31(2):153-162.

PMID: 39411950 DOI: 10.2174/0113816128312406241010081032.

IMPACT OF REAL-LIFE ENVIRONMENTAL EXPOSURES ON REPRODUCTION: Evidence for reproductive health effects following exposure to hydraulic fracturing chemical mixtures.

Siegel K, Berube R, Day M, Heldman S, Daley C, Murray B Reproduction. 2024; 168(4).

PMID: 39074054 PMC: 11377158. DOI: 10.1530/REP-24-0134.

An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis.

Risi R, Vidal-Puig A, Bidault G J Endocrinol. 2024; 262(1).

PMID: 38642584 PMC: 11227041. DOI: 10.1530/JOE-23-0313.

PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs.

Luan J, Ji X, Liu L Int J Mol Sci. 2023; 24(19).

PMID: 37833942 PMC: 10572723. DOI: 10.3390/ijms241914494.

Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS).

Ehrlich V, Bil W, Vandebriel R, Granum B, Luijten M, Lindeman B Environ Health. 2023; 22(1):19.

PMID: 36814257 PMC: 9944481. DOI: 10.1186/s12940-022-00958-5.

References

Barak Y, Nelson M, Ong E, Jones Y, Ruiz-Lozano P, Chien K . PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999; 4(4):585-95. DOI: 10.1016/s1097-2765(00)80209-9. View

Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K . PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999; 4(4):597-609. DOI: 10.1016/s1097-2765(00)80210-5. View

Rosen E, Sarraf P, Troy A, Bradwin G, Moore K, Milstone D . PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999; 4(4):611-7. DOI: 10.1016/s1097-2765(00)80211-7. View

Barroso I, Gurnell M, Crowley V, Agostini M, Schwabe J, Soos M . Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 2000; 402(6764):880-3. DOI: 10.1038/47254. View

Masugi J, Tamori Y, Mori H, Koike T, Kasuga M . Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun. 2000; 268(1):178-82. DOI: 10.1006/bbrc.2000.2096. View

Willson T, Brown P, Sternbach D, Henke B . The PPARs: from orphan receptors to drug discovery. J Med Chem. 2000; 43(4):527-50. DOI: 10.1021/jm990554g. View

Schoonjans K, Auwerx J . Thiazolidinediones: an update. Lancet. 2000; 355(9208):1008-10. DOI: 10.1016/S0140-6736(00)90002-3. View

Altshuler D, Hirschhorn J, Klannemark M, Lindgren C, Vohl M, Nemesh J . The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000; 26(1):76-80. DOI: 10.1038/79216. View

Dubois M, Pattou F, Kerr-Conte J, Gmyr V, Vandewalle B, Desreumaux P . Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells. Diabetologia. 2000; 43(9):1165-9. DOI: 10.1007/s001250051508. View

10.

Chawla A, Boisvert W, Lee C, Laffitte B, Barak Y, Joseph S . A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 2001; 7(1):161-71. DOI: 10.1016/s1097-2765(01)00164-2. View

11.

Luan J, Browne P, Harding A, Halsall D, ORahilly S, Chatterjee V . Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes. 2001; 50(3):686-9. DOI: 10.2337/diabetes.50.3.686. View

12.

Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K . Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med. 2001; 193(7):827-38. PMC: 2193371. DOI: 10.1084/jem.193.7.827. View

13.

Wang A, Dai X, Luu B, Conrad D . Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. Am J Respir Cell Mol Biol. 2001; 24(6):688-93. DOI: 10.1165/ajrcmb.24.6.4376. View

14.

Rosen E, Spiegelman B . PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001; 276(41):37731-4. DOI: 10.1074/jbc.R100034200. View

15.

Doney A, Fischer B, Cecil J, Boylan K, McGuigan F, Ralston S . Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. Diabetologia. 2004; 47(3):555-558. DOI: 10.1007/s00125-003-1323-1. View

16.

Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U, Kubota N . PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest. 2004; 113(6):846-55. PMC: 362117. DOI: 10.1172/JCI19900. View

17.

Imai T, Takakuwa R, Marchand S, Dentz E, Bornert J, Messaddeq N . Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A. 2004; 101(13):4543-7. PMC: 384783. DOI: 10.1073/pnas.0400356101. View

18.

Tenenbaum A, Motro M, Fisman E, Schwammenthal E, Adler Y, Goldenberg I . Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation. 2004; 109(18):2197-202. DOI: 10.1161/01.CIR.0000126824.12785.B6. View

19.

Hwangbo D, Gershman B, Gersham B, Tu M, Palmer M, Tatar M . Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004; 429(6991):562-6. DOI: 10.1038/nature02549. View

20.

Yliharsila H, Eriksson J, Forsen T, Laakso M, Uusitupa M, Osmond C . Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication. J Hypertens. 2004; 22(7):1283-7. DOI: 10.1097/01.hjh.0000125438.28861.a4. View